Navigation Links
Lifeline Biotechnologies Receives Third Software Patent
Date:9/17/2012

RENO, Nev., Sept. 17, 2012 /PRNewswire/ -- Lifeline Biotechnologies, Inc. (OTC Market: LLBO) announces the award of US Patent #8,231,542 B2 for System For Analyzing Thermal Data Based on Breast Surface Temperature to  Determine Suspect Conditions.

Jim Holmes, Lifeline's CEO said, "This System patent completes our group of three software patents.  We now have our Methods, Device and System patents which provide the Company with protection of its developed technology.  Methods for Collecting and Analyzing Thermal Data Based on Breast Surface Temperature to Determine Suspect Conditions;   Device For Analyzing Thermal Data Based On Breast Surface Temperature For Detection For Use In Determining Cancerous Conditions;  and, System For Analyzing Thermal Data Based On Breast Surface Temperature To Determine Suspect Conditions."

First Warning Systems, Lifeline Biotechnologies' exclusive licensee, is currently updating the patient data collection device and its interpretive software, covered by these patents, to complete the product package in preparation for market entry.  First Warning is conducting a funding round.  Company information is being posted on GUST (an association of angel investors who are accredited and qualified).

About First Warning Systems
First Warning Systems, (FWS) founded in 2008, is based in Reno, NV.  FWS' principal shareholder is Lifeline Biotechnologies, Inc.  Lifeline has licensed (includes a revenue royalty feature) FWS with the worldwide exclusive right for  development, manufacturing, marketing and commercialization of its intellectual property.  The product  is a device and process that detects breast tissue abnormalities.  Many of these tissue abnormalities will develop into breast diseases, some of which will be breast cancers.  The FWS process does not involve compression or radiation and is noninvasive. Three clinical trials with over 650 participants have achieved proof of concept and superior outcomes when compared to other protocols.  FWS is planning a final, limited clinical trial and a 510k device classification to validate the fourth generation of the FWS product. FWS is preparing to apply for a Euro CE Mark to market in the UK, EU and Russian markets. See FWS' video, "Breast Cancer Tumor Progression" at www.firstwarningsystems.com.

About Lifeline Biotechnologies
Lifeline Biotechnologies, Inc. (OTC Market: LLBO) founded in 1994 is based in Reno, NV.  LLBO has invested over $10M in a device and process for early detection of breast tissue abnormalities some of which are cancerous or pre-cancer.  Three "Proof of Concept" clinical trials of over 650 women have been completed and four patents (one hardware, three software) have been awarded. www.lbti.com. Lifeline's efforts continue to have DTC remove the chill and allow trading to resume.

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, the ability to obtain financing, successful development of the Company's product or market acceptance of the product and regulatory and shareholder approval for anticipated actions.

For more information, contact:   Jim Holmes, CEO 775-852-3222     Email: Jholmes@lbti.com           


'/>"/>
SOURCE Lifeline Biotechnologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Lifeline Biotechnologies First Warning Systems
2. Lifeline Biotechnologies, Inc. Receives Patent Award, a Device for Breast Tissue Temperature Analysis for Determining Cancer Conditions
3. Dehaier Medical Receives SFDA Approval for DHR-CPAP-C5
4. TechPrecision Receives Additional Medical Purchase Orders Exceeding $1.5 Million
5. Sinovac Receives Beijing CDC Tender Award to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
6. NeuroSigma Receives CE Certification
7. Surefire Medicals Infusion System For Embolization Procedures Receives CE Mark Approval
8. Roche receives FDA clearance for herpes simplex virus type 1 and 2 tests
9. NxStage Patient and Advocate Brian Hess Receives Prestigious Honor from American Association of Kidney Patients
10. AcelRx Pharmaceuticals Receives Fourth and Fifth U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
11. China Botanic Receives New Patent on its Comprehensive Method to Enhance the Medicinal Value of Schisandra
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2017)... -- Sapheneia and Scannerside received FDA 510(k) clearance to ... third-party Vendor neutral CT product that makes it affordable ... current MITA standards. ... specifically designed to provide CT operators, prior to a ... a predefined threshold. Scannerside Dose Check is intended to ...
(Date:9/5/2017)... , Sept. 5, 2017  Getinge, a ... created a vibrant charitable donation program -- "Color ... support congenital heart defect research by The Children,s ... and the general public are encouraged to download ... submit the completed artwork to the gallery on ...
(Date:9/5/2017)... 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... its meeting with the U.S. Food and Drug Administration ... At the meeting, ... for submission of ORMD-0801, would be a Biologics License ...
Breaking Medicine Technology:
(Date:9/22/2017)... (PRWEB) , ... September 22, 2017 , ... ... preserve fertility and create life. Although frozen embryos have a slight statistical advantage ... , “Egg freezing is a wonderful opportunity for women undergoing medical treatment or ...
(Date:9/21/2017)... Aliso Viejo, CA (PRWEB) , ... September 21, 2017 , ... ... never been so fun and easy to do. Users can select from up to ... more all with a click of a mouse all within Final Cut Pro ...
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... ... Sept. 26, 2017 — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/processcapabilityindices      ... easy to get things wrong, run afoul of The Quality System Regulation (§820.250), ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... Infinity Behavioral Health Services for professionals in the addiction treatment industry entitled: ... . , Insurance companies and state and federal governments are increasingly scrutinizing ...
(Date:9/21/2017)... IL. (PRWEB) , ... September 21, 2017 , ... ... results released today of a new member survey conducted by the International ... restoration procedures performed from 2014 to 2016 rose 60 percent, with 635,189 procedures ...
Breaking Medicine News(10 mins):